Fifth Third Bancorp’s Ascendis Pharma A/S ASND Stock Holding History

Fifth Third Bancorp’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.1K	Sell	188 -13	-6%	-$3.04K	﹤0.01%	3226
2026 Q1	$46K	Sell	201 -8	-4%	-$1.79K	﹤0.01%	3220
2025 Q4	$44.6K	Hold	209	–	–	﹤0.01%	1520
2025 Q3	$41.6K	Hold	209	–	–	﹤0.01%	1576
2025 Q2	$36.1K	Buy	209 +14	+7%	+$2.28K	﹤0.01%	1546
2025 Q1	$30.4K	Hold	195	–	–	﹤0.01%	1607
2024 Q4	$26.8K	Buy	195 +21	+12%	+$2.76K	﹤0.01%	1649
2024 Q3	$26K	Hold	174	–	–	﹤0.01%	1688
2024 Q2	$23.7K	Hold	174	–	–	﹤0.01%	1662
2024 Q1	$26.3K	Hold	174	–	–	﹤0.01%	1584
2023 Q4	$21.9K	Hold	174	–	–	﹤0.01%	1742
2023 Q3	$16.3K	Hold	174	–	–	﹤0.01%	1814
2023 Q2	$15.5K	Buy	174 +37	+27%	+$3.22K	﹤0.01%	1827
2023 Q1	$14.7K	Hold	137	–	–	﹤0.01%	1939
2022 Q4	$16.7K	Buy	137 +23	+20%	+$2.67K	﹤0.01%	1768
2022 Q3	$12K	Buy	114 +29	+34%	+$2.75K	﹤0.01%	1857
2022 Q2	$8K	Sell	85 -5	-6%	-$471	﹤0.01%	2067
2022 Q1	$11K	Buy	90 +55	+157%	+$6.37K	﹤0.01%	2008
2021 Q4	$5K	Hold	35	–	–	﹤0.01%	2309
2021 Q3	$6K	Hold	35	–	–	﹤0.01%	2139
2021 Q2	$5K	Hold	35	–	–	﹤0.01%	2185
2021 Q1	$5K	Buy	35 +4	+13%	+$608	﹤0.01%	2164
2020 Q4	$5K	Buy	31 +14	+82%	+$2.31K	﹤0.01%	2098
2020 Q3	$3K	Hold	17	–	–	﹤0.01%	1953
2020 Q2	$3K	Hold	17	–	–	﹤0.01%	1921
2020 Q1	$2K	Buy	+17	New	+$2.21K	﹤0.01%	1961

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fifth Third Bancorp's ASND Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Ascendis Pharma A/S (ASND) stake by 6.5% in Q2 2026, selling an estimated $3.04K and leaving 188 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3226.

Fifth Third Bancorp first reported a position in ASND in Q1 2020 and has held it in 26 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Fifth Third Bancorp held 188 shares of Ascendis Pharma A/S worth $50.1K as of Q2 2026.
Fifth Third Bancorp sold 13 Ascendis Pharma A/S shares in Q2 2026, an estimated $3.04K.
Ascendis Pharma A/S made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3226 holding.
Fifth Third Bancorp first reported a position in Ascendis Pharma A/S in Q1 2020 and has held it in 26 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.